Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Erlotinib can cause hair loss and texture changes.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Tofacitinib treatment for hair loss may worsen acne.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.